Sierra Ocean’s Acadia Pharmaceuticals ACAD Stock Holding History

Sierra Ocean’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-46	Closed	-$992	–	69
2025 Q2	$992	Sell	46 -68	-60%	-$1.26K	﹤0.01%	923
2025 Q1	$1.89K	Buy	+114	New	+$2.07K	﹤0.01%	794

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Sierra Ocean's ACAD Position: Q3 2025 in Review

Sierra Ocean sold out of Acadia Pharmaceuticals (ACAD) in Q3 2025, closing a stake of 46 shares — an estimated $992 sold.

Sierra Ocean first reported a position in ACAD in Q1 2025 and held it in 2 quarters. The position peaked at $1.89K in Q1 2025. 334 funds tracked by Wall St. Rank hold ACAD as of Q3 2025.

Sierra Ocean reported no remaining Acadia Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Sierra Ocean sold 46 Acadia Pharmaceuticals shares in Q3 2025, an estimated $992.
Sierra Ocean first reported a position in Acadia Pharmaceuticals in Q1 2025 and held it in 2 quarters.
Sierra Ocean's Acadia Pharmaceuticals position peaked at $1.89K in Q1 2025.
334 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2025.

Based on Sierra Ocean's 13F filing for Q3 2025, filed 7 Nov 2025.